The Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE): A Randomized Prospective Population-Based Study. Design and Baseline Characteristics

Verfasser / Beitragende:
[Katrine Rubin, Teresa Holmberg, Mette Rothmann, Mikkel Høiberg, Reinhard Barkmann, Jeppe Gram, Anne Hermann, Mickael Bech, Ole Rasmussen, Claus Glüer, Kim Brixen]
Ort, Verlag, Jahr:
2015
Enthalten in:
Calcified Tissue International, 96/2(2015-02-01), 167-179
Format:
Artikel (online)
ID: 605521638
LEADER caa a22 4500
001 605521638
003 CHVBK
005 20210128100741.0
007 cr unu---uuuuu
008 210128e20150201xx s 000 0 eng
024 7 0 |a 10.1007/s00223-014-9950-8  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00223-014-9950-8 
245 0 4 |a The Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE): A Randomized Prospective Population-Based Study. Design and Baseline Characteristics  |h [Elektronische Daten]  |c [Katrine Rubin, Teresa Holmberg, Mette Rothmann, Mikkel Høiberg, Reinhard Barkmann, Jeppe Gram, Anne Hermann, Mickael Bech, Ole Rasmussen, Claus Glüer, Kim Brixen] 
520 3 |a The risk-stratified osteoporosis strategy evaluation study (ROSE) is a randomized prospective population-based study investigating the effectiveness of a two-step screening program for osteoporosis in women. This paper reports the study design and baseline characteristics of the study population. 35,000 women aged 65-80years were selected at random from the population in the Region of Southern Denmark and—before inclusion—randomized to either a screening group or a control group. As first step, a self-administered questionnaire regarding risk factors for osteoporosis based on FRAX® was issued to both groups. As second step, subjects in the screening group with a 10-year probability of major osteoporotic fractures ≥15% were offered a DXA scan. Patients diagnosed with osteoporosis from the DXA scan were advised to see their GP and discuss pharmaceutical treatment according to Danish National guidelines. The primary outcome is incident clinical fractures as evaluated through annual follow-up using the Danish National Patient Registry. The secondary outcomes are cost-effectiveness, participation rate, and patient preferences. 20,904 (60%) women participated and included in the baseline analyses (10,411 in screening and 10,949 in control group). The mean age was 71years. As expected by randomization, the screening and control groups had similar baseline characteristics. Screening for osteoporosis is at present not evidence based according to the WHO screening criteria. The ROSE study is expected to provide knowledge of the effectiveness of a screening strategy that may be implemented in health care systems to prevent fractures. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Risk factors  |2 nationallicence 
690 7 |a Fracture prevention  |2 nationallicence 
690 7 |a Osteoporosis  |2 nationallicence 
690 7 |a Screening  |2 nationallicence 
690 7 |a Women  |2 nationallicence 
700 1 |a Rubin  |D Katrine  |u Odense Patient data Explorative Network (OPEN), Institute of Clinical Research, University of Southern Denmark, J. B. Winsløws Vej 9 a, 3th Floor, 5000, Odense C, Denmark  |4 aut 
700 1 |a Holmberg  |D Teresa  |u National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark  |4 aut 
700 1 |a Rothmann  |D Mette  |u Department of Medical Endocrinology, Odense University Hospital, Odense C, Denmark  |4 aut 
700 1 |a Høiberg  |D Mikkel  |u Department of Medical Endocrinology, Oslo University Hospital Aker, Oslo, Norway  |4 aut 
700 1 |a Barkmann  |D Reinhard  |u Section Biomedical Imaging, Department of Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, Germany  |4 aut 
700 1 |a Gram  |D Jeppe  |u Department of Endocrinology, Hospital of Southwest Denmark, Esbjerg, Denmark  |4 aut 
700 1 |a Hermann  |D Anne  |u Department of Medical Endocrinology, Odense University Hospital, Odense C, Denmark  |4 aut 
700 1 |a Bech  |D Mickael  |u Department of Business and Economics, COHERE, University of Southern Denmark, Odense, Denmark  |4 aut 
700 1 |a Rasmussen  |D Ole  |u Department of Internal Medicine, Sygehus Lillebælt, Kolding, Denmark  |4 aut 
700 1 |a Glüer  |D Claus  |u Section Biomedical Imaging, Department of Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, Germany  |4 aut 
700 1 |a Brixen  |D Kim  |u Department of Medical Endocrinology, Odense University Hospital, Odense C, Denmark  |4 aut 
773 0 |t Calcified Tissue International  |d Springer US; http://www.springer-ny.com  |g 96/2(2015-02-01), 167-179  |x 0171-967X  |q 96:2<167  |1 2015  |2 96  |o 223 
856 4 0 |u https://doi.org/10.1007/s00223-014-9950-8  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00223-014-9950-8  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Rubin  |D Katrine  |u Odense Patient data Explorative Network (OPEN), Institute of Clinical Research, University of Southern Denmark, J. B. Winsløws Vej 9 a, 3th Floor, 5000, Odense C, Denmark  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Holmberg  |D Teresa  |u National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Rothmann  |D Mette  |u Department of Medical Endocrinology, Odense University Hospital, Odense C, Denmark  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Høiberg  |D Mikkel  |u Department of Medical Endocrinology, Oslo University Hospital Aker, Oslo, Norway  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Barkmann  |D Reinhard  |u Section Biomedical Imaging, Department of Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Gram  |D Jeppe  |u Department of Endocrinology, Hospital of Southwest Denmark, Esbjerg, Denmark  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Hermann  |D Anne  |u Department of Medical Endocrinology, Odense University Hospital, Odense C, Denmark  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bech  |D Mickael  |u Department of Business and Economics, COHERE, University of Southern Denmark, Odense, Denmark  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Rasmussen  |D Ole  |u Department of Internal Medicine, Sygehus Lillebælt, Kolding, Denmark  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Glüer  |D Claus  |u Section Biomedical Imaging, Department of Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Brixen  |D Kim  |u Department of Medical Endocrinology, Odense University Hospital, Odense C, Denmark  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Calcified Tissue International  |d Springer US; http://www.springer-ny.com  |g 96/2(2015-02-01), 167-179  |x 0171-967X  |q 96:2<167  |1 2015  |2 96  |o 223